D2 Pharma Consulting
Chesterfield, US
Healthtech
Founders & leadership
DP
Dean P ErhardtExecutive Officer, Director
SK
Steven KirchofDirector
RP
Richard PropperDirector
JW
John WagnerDirector
DS
David SuchanekDirector
Reported raises · per SEC filings
Form D private placements▶$1.6MraisedJan 2023 · 4 investors · Other Health CareRule 506(b)
▶$1.6MraisedJan 2023 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dean P ErhardtExecutive Officer, Director
- Steven KirchofDirector
- Richard PropperDirector
- John WagnerDirector
- David SuchanekDirector
- Offering amount
- $3M
- Amount sold
- $1.6M
- Minimum investment
- $100K
- First sale
- Dec 2022
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.